Asaf Maoz, Medical Oncologist at Dana-Farber Cancer Institute, shared Li-Fraumeni Syndrome Association’s post on LinkedIn, adding:
“Dr. Garber has been an incredible force in advancing Li-Fraumeni Syndrome clinical care and research.
I am so happy to see her recognized with this award.”
Quoting Li-Fraumeni Syndrome Association’s post:
“It was our great pleasure to recognize Dr. Judy Garber of Dana-Farber Cancer Institute with the LFSA Global Pioneer Award yesterday.
Her distinguished career and commitment to the Li-Fraumeni syndrome community – and to advancing women in the field – has made a profound positive impact.
If you missed her session on Leiomyosarcoma in LFS, sessions will be loaded to the app for virtual participants within 24-48 hours.
You can still sign up for live and archived access of the 8th International LFS Association, presented by Abbott.
We’re starting another info-packed day at UT MD Anderson.”
Other articles about Li-Fraumeni Syndrome on OncoDaily.